| Literature DB >> 34371224 |
Ching-Nung Wu1, Sheng-Dean Luo2, Hsin-Ching Lin2, Jui-Ting Huang3, Chih-Hung Lee4, Song-Yan Liu5, Ming-Hsien Tsai2, Chih-Chi Wang6, Sheng Fan7, Pi-Sheng Wang8, Kuo-Chung Lan9.
Abstract
BACKGROUND: Unequal access to healthcare is a global medical problem. Telemedicine, recently made possible by technological advances, may mitigate this inequity. However, the usefulness of telemedicine for procedure-driven disciplines, such as otolaryngology, under infectious conditions (e.g., the COVID-19 pandemic) is unknown.Entities:
Keywords: COVID-19; Eligibility; Otolaryngology; Telemedicine
Mesh:
Year: 2021 PMID: 34371224 PMCID: PMC8556875 DOI: 10.1016/j.bj.2021.07.012
Source DB: PubMed Journal: Biomed J ISSN: 2319-4170 Impact factor: 4.910
Fig. 1Live, interactive telemedicine practice. (A) The physician is able to remotely zoom the camera to actively monitor the patient, (B) which facilitates the clinical workflow when working with a telemedicine examiner. Using digital hand-held diagnostic tools, including (C) a fiberscope (arrow) and (D) a rigid scope (arrowhead), the physician is able to perform real-time endoscopic examinations of the larynx and nose using the telemedicine system. (E) Treatment procedure, such as cerumen removal, could be performed as well under the supervision of the specialist.
Ten most common otolaryngology diagnoses made between November 2018 and May 2020 using the telemedicine service, stratified according to hospital site.
| CGBTH | KCGMH | ||||
|---|---|---|---|---|---|
| Diagnosis | Number (%) | Site | Diagnosis | Number | Site |
| Impacted cerumen | 25 (9.2%) | E | Chronic rhinitis | 38015 | N |
| Chronic otitis externa | 22 (8.1%) | E | Hearing loss | 26158 | E |
| Otitis media | 22 (8.1%) | E | Oral cavity cancer | 23848 | T |
| Tinnitus | 20 (7.4%) | E | Chronic rhinosinusitis | 15795 | N |
| Vertigo/dizziness | 17 (6.3%) | E | Tinnitus | 15387 | E |
| Oral mucositis | 15 (5.6%) | T | Chronic pharyngitis | 14673 | T |
| Chronic rhinitis | 14 (5.2%) | N | Oral leukoplakia | 09505 | T |
| Hearing loss | 12 (4.4%) | E | Deviated nasal septum | 07868 | N |
| Oral leukoplakia | 12 (4.4%) | T | Sleep apnea | 07647 | T |
| Chronic rhinosinusitis | 10 (3.7%) | N | Vertigo/dizziness | 07640 | E |
| Total | 62.4% | ||||
Abbreviations: CGBTH: Chenggong Branch of Taitung Hospital; E: ear; KCGMH: Kaohsiung Chang Gung Memorial Hospital; N: nose; T: throat.
Percentages of the most common ear, nose, and throat complaints deemed eligible for telemedicine. Patients who did not require a specialized diagnosis procedure were considered eligible for telemedicine.
| Ear | Nose | Throat | |||
|---|---|---|---|---|---|
| Diagnosis | Percentage | Diagnosis | Percentage | Diagnosis | Percentage |
| Vertigo/dizziness | 10.6% | Chronic rhinitis | 4.9% | Oral mucositis | 9.9% |
| Tinnitus | 09.9% | Chronic rhinosinusitis | 4.9% | Acute pharyngitis | 4.9% |
| Chronic otitis externa | 07.0% | Oral leukoplakia | 4.9% | ||
| Hearing loss | 05.6% | ||||
| Total | 33.1% | Total | 9.8% | Total | 19.7% |
Fig. 2Patient satisfaction rate, case closure rate, and rate of return in 2018 (introduction of the telemedicine service), 2019, and 2020 (the COVID-19 pandemic). The patient subjective improvement rate increased over the study period, from 62.0% in the first year (2018) to 78.9% in the third year (2020). The rate of return and the case closure rate were around 90% in 2018 and 2019. However, the rate of return decreased to 57.1% in 2020 during the COVID-19 pandemic, while the patient subjective improvement rate and the case closure rate remained high.
Comparisons of most common diagnoses before and during the COVID-19 pandemic.
| Pre-COVID-19 | During COVID-19 | ||||
|---|---|---|---|---|---|
| Diagnosis | Number (%) | Site | Diagnosis | Number (%) | Site |
| Impacted cerumen | 23 (9.4%) | E | Tinnitus | 4 (16.0%) | E |
| Otitis media | 22 (9.0%) | E | Vertigo/dizziness | 3 (12.0%) | E |
| Chronic otitis externa | 20 (8.2%) | E | Vocal cord disorders | 3 (12.0%) | T |
| Tinnitus | 16 (6.5%) | E | Impacted cerumen | 2 (08.0%) | E |
| Oral mucositis | 15 (6.1%) | T | Chronic otitis externa | 2 (08.0%) | E |
| Vertigo/dizziness | 14 (5.7%) | E | Otalgia | 2 (08.0%) | E |
| Chronic rhinitis | 12 (4.9%) | N | Chronic rhinitis | 2 (08.0%) | N |
| Hearing loss | 11 (4.5%) | E | Chronic pharyngitis | 2 (08.0%) | T |
| Oral leukoplakia | 11 (4.5%) | T | – | – | – |
| Chronic rhinosinusitis | 10 (4.1%) | N | – | – | – |
| Total | 62.9% | Total | 80.0% | ||
Abbreviations: E: ear; N: nose; T: throat.